For the quarter ending 2026-03-31, CPMV has $9,828 in assets. $7,661,199 in debts. $72 in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Prepaid expenses and other current assets | - | - | 23,537 | 4,116 |
| Cash and cash equivalents | 72 | 3,622 | 31,761 | 53,583 |
| Prepaid expenses and other current assets | 9,756 | 16,260 | - | - |
| Total current assets | 9,828 | 19,882 | 55,298 | 57,699 |
| Total assets | 9,828 | 19,882 | 55,298 | 57,699 |
| Accounts payable | 167,058 | 132,784 | 133,759 | 133,808 |
| Accrued compensation | 4,370,369 | 4,254,208 | 4,135,109 | 4,011,998 |
| Accrued consulting | 787,903 | 787,903 | 787,903 | 787,903 |
| Accrued expenses and other | 651,940 | 655,160 | 658,047 | 636,632 |
| Loan payable | 200,000 | 200,000 | 200,000 | 200,000 |
| Total current liabilities | 6,177,270 | 6,030,055 | 5,914,818 | 5,770,341 |
| Convertible notes, net | 1,483,929 | 1,465,847 | 1,447,363 | 1,428,880 |
| Total liabilities | 7,661,199 | 7,495,902 | 7,362,181 | 7,199,221 |
| Preferred stock, value-Series APreferred Stock | 0 | 0 | 0 | 0 |
| Preferred stock, value | - | - | - | 0 |
| Preferred stock, value-Series BPreferred Stock | 1 | 1 | 1 | 1 |
| Common stock, 0.00001 par value 100,000,000 shares authorized 7,242,137 shares issued and outstanding | 72 | 72 | 72 | 72 |
| Additional paid-in capital | 2,050,073 | 2,050,073 | 2,050,073 | 2,050,073 |
| Accumulated deficit | -9,701,517 | -9,526,166 | -9,357,029 | -9,191,668 |
| Total stockholders deficit | -7,651,371 | -7,476,020 | -7,306,883 | -7,141,522 |
| Total liabilities and stockholders deficit | 9,828 | 19,882 | 55,298 | 57,699 |
Mosaic ImmunoEngineering Inc. (CPMV)
Mosaic ImmunoEngineering Inc. (CPMV)